Ignite Creation Date:
2024-05-05 @ 10:08 PM
Last Modification Date:
2024-10-26 @ 10:14 AM
Study NCT ID:
NCT01037036
Status:
COMPLETED
Last Update Posted:
2014-01-10
First Post:
2009-12-17
Brief Title:
A Study of the L-PPDS With Adjunctive Xalatan Eye Drops in Subjects With OH or OAG
Sponsor:
Mati Therapeutics Inc
Organization:
Mati Therapeutics Inc
Study Overview
Official Title:
An Open-Label Phase 2 Study of the Latanoprost Punctal Plug Delivery System L-PPDS With Adjunctive Xalatan Eye Drops in Subjects With Ocular Hypertension OH or Open-Angle Glaucoma OAG
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to investigate how the intraocular pressure IOP-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None